ChartRow logo
Sign in
STE
$221.50-1.63%
as of close, Oct 21, 2026
☾ AH $221.50 -1.63%
STERIS plc (Ireland)Stock · HealthcareS&P 500 Equal Weight · 0.2% of RSPS&P 500 · 0.03% of SPYRussell 1000 · 0.03% of IWBUS Stock Market · 0.03% of VTIRussell 3000 · 0.03% of IWVMSCI World · 0.02% of URTHMSCI ACWI · 0.02% of ACWI
PeersEWZBHGEHCPHGPENSNN
Share this page

STE SEC filings (2026)

CIK 1757898 · Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842) · incorporated in L2 · fiscal year ends in March

680 filings on EDGAR since 2018 · 8 annual, 22 quarterly, 64 current · financial statements · earnings

Latest 10-K
May 29, 2026
fiscal year to Mar 31, 2026
Latest 10-Q
Aug 7, 2026
quarter to Jun 30, 2026
Latest 8-K
Oct 13, 2026
Material definitive agreement
Last earnings release
Aug 5, 2026
$2.59 vs $2.54 · ▼ 0.4%
Filings on file
680
since 2018, 484 insider forms

What happened, last 12 months#

Every earnings release with its print, every report with its quarter, the other 8-Ks by the headline of the press release they furnish or by their items, the proxy statements, and each day an insider bought or sold — newest first, each line opening the filing on EDGAR. The index by form and year follows.

October 2026

August 2026

June 2026

May 2026

April 2026

March 2026

February 2026

November 2025

Insider transactions#

What officers, directors and 10% holders reported on Forms 4 and 5 over the last 13 months, from the documents themselves: one insider’s trades of one kind on one day are one row, with the shares, the price range and the total as filed. Open-market buys and sells first; awards, exercises, tax withholding, gifts and employee-plan purchases are grouped below them.

Over the last 13 months insiders sold $3.2M in 6 sales and bought nothing on the open market; 75 other transactions (awards, exercises, tax withholding, gifts and plan purchases).

DateInsider
Aug 12, 2026Form 4Sohi MohsenDirectorSold · $957K · 4,058 sh
Jun 15, 2026Form 4Zangerle John AdamSr. VP, Gen Counsel, and Sec.Sold · $297K · 1,419 sh · 10b5-1
Jun 5, 2026Form 4Carestio Daniel APresident and CEO · DirectorSold · $291K · 1,374 sh · 10b5-1
Jun 4, 2026Form 4Carestio Daniel APresident and CEO · DirectorSold · $656K · 3,054 sh · 10b5-1
Jun 2, 2026Form 4Breeden Richard CDirectorSold · $310K · 1,481 sh
Mar 5, 2026Form 4FELDMANN CYNTHIA LDirectorSold · $735K · 3,098 sh
Awards, exercises, withholding and plan purchases · 75 transactions
DateInsider
Oct 1, 2026Form 4Burton Karen LSr. Vice Pres., CFOTax withholding · $0 · 228 sh
Aug 12, 2026Form 4Sohi MohsenDirectorExercise or conversion · $350K · 4,058 sh
Aug 12, 2026Form 4Sohi MohsenDirectorExercise or conversion · Director Stock Option (rig… · $0 · 4,058 sh
Aug 10, 2026Form 4Alegria Esther M.DirectorAward · Director Stock Option (rig… · $0 · 1,506 sh
Aug 10, 2026Form 4FELDMANN CYNTHIA LDirectorAward · Director Stock Option (rig… · $0 · 1,506 sh
Aug 10, 2026Form 4Martin Paul EdwardDirectorAward · Director Stock Option (rig… · $0 · 1,506 sh
Aug 10, 2026Form 4Shah Nirav RDirectorAward · Director Stock Option (rig… · $0 · 1,506 sh
Aug 10, 2026Form 4Sohi MohsenDirectorAward · Career Restricted Stock Un… · $0 · 1,229 sh
Aug 10, 2026Form 4Sohi MohsenDirectorAward · Director Stock Option (rig… · $0 · 1,099 sh
Aug 10, 2026Form 4Boulud PierreDirectorAward · Career Restricted Stock Un… · $0 · 1,025 sh
Aug 10, 2026Form 4HOLLAND CHRISTOPHER SDirectorAward · Career Restricted Stock Un… · $0 · 1,025 sh
Aug 10, 2026Form 4Shapiro LouisDirectorAward · Career Restricted Stock Un… · $0 · 1,025 sh
Aug 10, 2026Form 4Alegria Esther M.DirectorAward · Career Restricted Stock Un… · $0 · 512 sh
Aug 10, 2026Form 4FELDMANN CYNTHIA LDirectorAward · Career Restricted Stock Un… · $0 · 512 sh
Aug 10, 2026Form 4Martin Paul EdwardDirectorAward · Career Restricted Stock Un… · $0 · 512 sh
Aug 10, 2026Form 4Shah Nirav RDirectorAward · Career Restricted Stock Un… · $0 · 512 sh
Jul 1, 2026Form 4Sohi MohsenDirectorTax withholding · $390K · 1,837 sh
Jul 1, 2026Form 4Sohi MohsenDirectorExercise or conversion · $270K · 3,781 sh
Jul 1, 2026Form 4Sohi MohsenDirectorExercise or conversion · Director Stock Option (rig… · $0 · 3,781 sh
Jun 4, 2026Form 4Carestio Daniel APresident and CEO · DirectorTax withholding · $401K · 1,889 sh · 10b5-1
Jun 4, 2026Form 4Fraser Mary ClareSVP & Chief HROTax withholding · $127K · 600 sh
Jun 4, 2026Form 4Zangerle John AdamSr. VP, Gen Counsel, and Sec.Tax withholding · $85K · 401 sh
Jun 4, 2026Form 4Madsen JuliaSr. VP and GM, Life SciencesTax withholding · $41K · 195 sh
Jun 4, 2026Form 4Kohler Kenneth ESVP & GM, ASTTax withholding · $32K · 150 sh
Jun 4, 2026Form 4Burton Karen LSr. Vice Pres., CFOTax withholding · $19K · 90 sh
Jun 4, 2026Form 4Tamaro RenatoV.P. & Corporate TreasurerTax withholding · $14K · 65 sh
Jun 3, 2026Form 4Carestio Daniel APresident and CEO · DirectorTax withholding · $550K · 2,619 sh
Jun 3, 2026Form 4Zangerle John AdamSr. VP, Gen Counsel, and Sec.Tax withholding · $77K · 365 sh
Jun 3, 2026Form 4Fraser Mary ClareSVP & Chief HROTax withholding · $65K · 311 sh
Jun 3, 2026Form 4Madsen JuliaSr. VP and GM, Life SciencesTax withholding · $50K · 239 sh
Jun 3, 2026Form 4Burton Karen LSr. Vice Pres., CFOTax withholding · $40K · 190 sh
Jun 3, 2026Form 4Kohler Kenneth ESVP & GM, ASTTax withholding · $39K · 184 sh
Jun 3, 2026Form 4Tamaro RenatoV.P. & Corporate TreasurerTax withholding · $13K · 64 sh
Jun 2, 2026Form 4Breeden Richard CDirectorExercise or conversion · $270K · 3,781 sh
Jun 2, 2026Form 4Carestio Daniel APresident and CEO · DirectorTax withholding · $209K · 995 sh
Jun 2, 2026Form 4Fraser Mary ClareSVP & Chief HROTax withholding · $124K · 591 sh
Jun 2, 2026Form 4McGowan LindseyVP, Chf. Comp. & Quality Offc.Tax withholding · $69K · 329 sh
Jun 2, 2026Form 4Zangerle John AdamSr. VP, Gen Counsel, and Sec.Tax withholding · $52K · 247 sh
Jun 2, 2026Form 4Madsen JuliaSr. VP and GM, Life SciencesTax withholding · $27K · 127 sh
Jun 2, 2026Form 4Majors Cary LSVP and President, HealthcareTax withholding · $14K · 67 sh
Jun 2, 2026Form 4Burton Karen LSr. Vice Pres., CFOExercise or conversion · $14K · 66 sh
Jun 2, 2026Form 4Kohler Kenneth ESVP & GM, ASTTax withholding · $14K · 66 sh
Jun 2, 2026Form 4Tamaro RenatoV.P. & Corporate TreasurerTax withholding · $8,600 · 41 sh
Jun 2, 2026Form 4Carestio Daniel APresident and CEO · DirectorAward · Employee Stock Option (rig… · $0 · 82,740 sh
Jun 2, 2026Form 4Carestio Daniel APresident and CEO · DirectorAward · $0 · 23,736 sh
Jun 2, 2026Form 4Burton Karen LSr. Vice Pres., CFOAward · Employee Stock Option (rig… · $0 · 18,564 sh
Jun 2, 2026Form 4Majors Cary LSVP and President, HealthcareAward · Employee Stock Option (rig… · $0 · 16,548 sh
Jun 2, 2026Form 4Zangerle John AdamSr. VP, Gen Counsel, and Sec.Award · Employee Stock Option (rig… · $0 · 15,200 sh
Jun 2, 2026Form 4Fraser Mary ClareSVP & Chief HROAward · Employee Stock Option (rig… · $0 · 10,492 sh
Jun 2, 2026Form 4Madsen JuliaSr. VP and GM, Life SciencesAward · Employee Stock Option (rig… · $0 · 8,080 sh
Jun 2, 2026Form 4Kohler Kenneth ESVP & GM, ASTAward · Employee Stock Option (rig… · $0 · 7,668 sh
Jun 2, 2026Form 4Burton Karen LSr. Vice Pres., CFOAward · $0 · 5,325 sh
Jun 2, 2026Form 4Majors Cary LSVP and President, HealthcareAward · $0 · 4,746 sh
Jun 2, 2026Form 4Zangerle John AdamSr. VP, Gen Counsel, and Sec.Award · $0 · 4,359 sh
Jun 2, 2026Form 4McGowan LindseyVP, Chf. Comp. & Quality Offc.Award · Employee Stock Option (rig… · $0 · 4,036 sh
Jun 2, 2026Form 4Breeden Richard CDirectorExercise or conversion · Employee Stock Option (rig… · $0 · 3,781 sh
Jun 2, 2026Form 4Fraser Mary ClareSVP & Chief HROAward · $0 · 3,009 sh
Jun 2, 2026Form 4Tamaro RenatoV.P. & Corporate TreasurerAward · Employee Stock Option (rig… · $0 · 2,620 sh
Jun 2, 2026Form 4Madsen JuliaSr. VP and GM, Life SciencesAward · $0 · 2,316 sh
Jun 2, 2026Form 4Kohler Kenneth ESVP & GM, ASTAward · $0 · 2,199 sh
Jun 2, 2026Form 4McGowan LindseyVP, Chf. Comp. & Quality Offc.Award · $0 · 1,155 sh
Jun 2, 2026Form 4Tamaro RenatoV.P. & Corporate TreasurerAward · $0 · 750 sh
Jun 2, 2026Form 4Boulud PierreDirectorAward · Career Restricted Stock Un… · $0 · 367 sh
Jun 1, 2026Form 4Carestio Daniel APresident and CEO · DirectorTax withholding · $0 · 1,254 sh
Jun 1, 2026Form 4Majors Cary LSVP and President, HealthcareTax withholding · $0 · 768 sh
Jun 1, 2026Form 4Fraser Mary ClareSVP & Chief HROTax withholding · $0 · 673 sh
Jun 1, 2026Form 4Zangerle John AdamSr. VP, Gen Counsel, and Sec.Tax withholding · $0 · 337 sh
Jun 1, 2026Form 4Madsen JuliaSr. VP and GM, Life SciencesTax withholding · $0 · 208 sh
Jun 1, 2026Form 4McGowan LindseyVP, Chf. Comp. & Quality Offc.Tax withholding · $0 · 198 sh
Jun 1, 2026Form 4Kohler Kenneth ESVP & GM, ASTTax withholding · $0 · 109 sh
Jun 1, 2026Form 4Burton Karen LSr. Vice Pres., CFOTax withholding · $0 · 99 sh
Jun 1, 2026Form 4Tamaro RenatoV.P. & Corporate TreasurerTax withholding · $0 · 81 sh
Mar 5, 2026Form 4FELDMANN CYNTHIA LDirectorExercise or conversion · $472K · 3,098 sh
Mar 5, 2026Form 4FELDMANN CYNTHIA LDirectorExercise or conversion · Director Stock Option (rig… · $0 · 3,098 sh
Jan 2, 2026Form 4McGowan LindseyVP, Chf. Comp. & Quality Offc.Award · $0 · 798 sh

Reports and proxy statements#

Annual reports (10-K, 20-F, 40-F), quarterly reports (10-Q), current reports (8-K, 6-K) and proxy statements, newest first. An 8-K that furnishes a press release is headed by the release’s headline, its items beneath; any other 8-K is described by its items. A form opens the press release where there is one, else the document on EDGAR, or the filing’s index where it furnishes other exhibits.

2026 · 14 filings
FiledWhat it is
Oct 13, 20268-KMaterial definitive agreement
Aug 7, 202610-QQuarterly report, Q1 FY2027 — revenue $1.49B (+7% y/y), net income $200.1M
Aug 6, 20268-KShareholder vote results
Aug 6, 20268-K/ADirectors or officers; compensation
Aug 5, 20268-KEarnings release — EPS $2.59 vs $2.54 est. (+2.0%); revenue $1.49B (+7% y/y) 0.4%
Jun 11, 2026ARSAnnual report to shareholders
Jun 11, 2026DEFA14AAdditional proxy materials
Jun 11, 2026DEF 14AProxy statement
May 29, 202610-KAnnual report, FY2026 — revenue $5.94B (+9% y/y), net income $782.3M, EPS $7.93
May 11, 20268-KEarnings release — EPS $2.83 vs $2.86 est. (−1.1%); revenue $1.59B (+7% y/y) 4.5%
May 7, 20268-KSTERIS Appoints Pierre Boulud to Board of DirectorsDirectors or officers; compensation; Regulation FD disclosure
Apr 6, 20268-KDirectors or officers; compensation
Feb 6, 202610-QQuarterly report, Q3 FY2026 — revenue $1.50B (+9% y/y), net income $192.9M, EPS $1.96
Feb 4, 20268-KEarnings release — EPS $2.53 vs $2.53 est. (+0.0%); revenue $1.50B (+9% y/y) 7.7%
2025 · 14 filings
FiledWhat it is
Nov 6, 202510-QQuarterly report, Q2 FY2026 — revenue $1.46B (+10% y/y), net income $191.9M, EPS $1.94
Nov 5, 20258-KEarnings release — EPS $2.47 vs $2.38 est. (+3.8%); revenue $1.46B (+10% y/y) 6.9%
Aug 7, 202510-QQuarterly report, Q1 FY2026 — revenue $1.39B (+9% y/y), net income $177.4M, EPS $1.79
Aug 6, 20258-KEarnings release — EPS $2.34 vs $2.32 est. (+0.9%); revenue $1.39B (+9% y/y) 6.8%
Jul 3, 2025DEFA14AAdditional proxy materials
Jul 3, 20258-KDirectors or officers; compensation
Jun 12, 2025ARSAnnual report to shareholders
Jun 12, 2025DEFA14AAdditional proxy materials
Jun 12, 2025DEF 14AProxy statement
May 29, 202510-KAnnual report, FY2025 — revenue $5.46B (+6% y/y), net income $614.6M, EPS $6.20
May 14, 20258-KEarnings release — EPS $2.74 vs $2.59 est. (+5.8%); revenue $1.48B (+4% y/y) 8.5%
Mar 3, 20258-KOther events
Feb 7, 202510-QQuarterly report, Q3 FY2025 — revenue $1.37B (+6% y/y), net income $173.5M, EPS $1.75
Feb 5, 20258-KEarnings release — EPS $2.32 vs $2.32 est.; revenue $1.37B (+6% y/y) 2.1%
2024 · 15 filings
FiledWhat it is
Nov 7, 202410-QQuarterly report, Q2 FY2025 — revenue $1.33B (+7% y/y), net income $150.0M, EPS $1.51
Nov 6, 20248-KEarnings release — EPS $2.14 vs $2.11 est. (+1.4%); revenue $1.33B (+7% y/y) 5.3%
Oct 7, 20248-KMaterial definitive agreement; New financial obligation
Aug 8, 202410-QQuarterly report, Q1 FY2025 — revenue $1.28B (+8% y/y), net income $145.4M, EPS $1.46
Aug 6, 20248-KEarnings release — EPS $2.03 vs $2.01 est. (+1.0%); revenue $1.28B (+8% y/y) 2.4%
Aug 1, 20248-KShareholder vote results
Jun 12, 2024ARSAnnual report to shareholders
Jun 12, 2024DEFA14AAdditional proxy materials
Jun 12, 2024DEF 14AProxy statement
May 31, 20248-KRegulation FD disclosure
May 29, 202410-KAnnual report, FY2024 — revenue $5.14B (+13% y/y), net income $378.2M, EPS $3.81
May 8, 20248-KEarnings release — EPS $2.41 vs $2.41 est.; revenue $1.42B (+11% y/y) 7.6%
Apr 11, 20248-KMaterial definitive agreement; Regulation FD disclosure
Feb 8, 202410-QQuarterly report, Q3 FY2024 — revenue $1.30B (+17% y/y), net income $140.7M, EPS $1.42
Feb 7, 20248-KEarnings release — EPS $2.22 vs $2.17 est. (+2.3%); revenue $1.30B (+17% y/y) 2.5%
2023 · 16 filings — 7 × 8-K, 3 × 10-Q, 2 × 8-K/A and 4 other forms
FiledWhat it is
Nov 7, 202310-QQuarterly report, Q2 FY2024 — revenue $1.24B (+13% y/y), net income $115.3M, EPS $1.16
Aug 8, 202310-QQuarterly report, Q1 FY2024 — revenue $1.18B (+13% y/y), net income $123.6M, EPS $1.25
Jun 7, 2023ARSAnnual report to shareholders
Jun 7, 2023DEFA14AAdditional proxy materials
Jun 7, 2023DEF 14AProxy statement
May 26, 202310-KAnnual report, FY2023 — revenue $4.54B (+7% y/y), net income $107.0M, EPS $1.07
Feb 8, 202310-QQuarterly report, Q3 FY2023 — revenue $1.11B (−8% y/y), net income $123.8M, EPS $1.24

9 current reports (8-K) not listed; the year is on EDGAR.

2022 · 12 filings — 6 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
FiledWhat it is
Nov 9, 202210-QQuarterly report, Q2 FY2023 — revenue $1.09B (−9% y/y), net income −$315.3M, EPS −$3.15
Aug 8, 202210-QQuarterly report, Q1 FY2023 — revenue $1.05B (+9% y/y), net income $111.3M, EPS $1.10
Jun 7, 2022DEFA14AAdditional proxy materials
Jun 7, 2022DEF 14AProxy statement
May 31, 202210-KAnnual report, FY2022 — revenue $4.22B (+36% y/y), net income $243.9M, EPS $2.48
Feb 9, 202210-QQuarterly report, Q3 FY2022 — revenue $1.21B (+49% y/y), net income $143.6M, EPS $1.42

6 current reports (8-K) not listed; the year is on EDGAR.

2021 · 21 filings — 14 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
FiledWhat it is
Nov 8, 202110-QQuarterly report, Q2 FY2022 — revenue $1.20B (+58% y/y), net income $69.8M, EPS $0.69
Aug 9, 202110-QQuarterly report, Q1 FY2022 — revenue $968.4M (+45% y/y), net income −$21.8M, EPS −$0.24
Jun 7, 2021DEFA14AAdditional proxy materials
Jun 7, 2021DEF 14AProxy statement
May 28, 202110-KAnnual report, FY2021 — revenue $3.11B (+3% y/y), net income $397.4M, EPS $4.63
Feb 9, 202110-QQuarterly report, Q3 FY2021 — revenue $808.9M (+4% y/y), net income $114.5M, EPS $1.33

15 current reports (8-K) not listed; the year is on EDGAR.

2020 · 12 filings — 6 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
FiledWhat it is
Nov 6, 202010-QQuarterly report, Q2 FY2021 — revenue $756.1M (+3% y/y), net income $105.9M, EPS $1.23
Aug 7, 202010-QQuarterly report, Q1 FY2021 — revenue $668.9M (−4% y/y), net income $89.6M, EPS $1.05
Jun 5, 2020DEFA14AAdditional proxy materials
Jun 5, 2020DEF 14AProxy statement
May 29, 202010-KAnnual report, FY2020 — revenue $3.03B (+9% y/y), net income $407.7M, EPS $4.76
Feb 10, 202010-QQuarterly report, Q3 FY2020 — revenue $774.3M (+11% y/y), net income $104.9M, EPS $1.23

6 current reports (8-K) not listed; the year is on EDGAR.

2019 · 11 filings — 6 × 8-K, 2 × 10-Q, 1 × 10-K and 2 other forms
FiledWhat it is
Nov 7, 201910-QQuarterly report, Q2 FY2020 — revenue $736.8M (+9% y/y), net income $94.8M, EPS $1.11
Aug 7, 201910-QQuarterly report, Q1 FY2020 — revenue $696.8M (+9% y/y), net income $85.4M, EPS $1.00
Jun 5, 2019DEFA14AAdditional proxy materials
Jun 5, 2019DEF 14AProxy statement
May 30, 201910-KAnnual report, FY2019 — revenue $2.78B (+6% y/y), net income $303.7M, EPS $3.55

6 current reports (8-K) not listed; the year is on EDGAR.

Insider, ownership and other filings#

Insider ownership (Forms 3, 4, 5 and 144), beneficial ownership (Schedules 13D and 13G), registration and prospectus (S-1, S-3, S-8, 424B and related) and the rest, counted by year, with the newest 25 of each of the latest 3 years shown. A Form 4 is one insider’s transaction report; a 13G is a passive holder above five percent.

2026 · 62 filings — 47 × 4, 7 × 144, 3 × SCHEDULE 13G and 4 other forms
FiledWhat it is
Oct 5, 20264Insider transaction (Form 4)
Aug 18, 2026144Notice of proposed sale (Form 144)
Aug 12, 20264Insider transaction (Form 4)
Aug 12, 20264Insider transaction (Form 4)
Aug 12, 20264Insider transaction (Form 4)
Aug 12, 20264Insider transaction (Form 4)
Aug 12, 20264Insider transaction (Form 4)
Aug 12, 20264Insider transaction (Form 4)
Aug 12, 20264Insider transaction (Form 4)
Aug 12, 20264Insider transaction (Form 4)
Aug 12, 2026144Notice of proposed sale (Form 144)
Jul 2, 20264Insider transaction (Form 4)
Jun 16, 202611-KEmployee plan annual report
Jun 16, 20264Insider transaction (Form 4)
Jun 15, 2026144Notice of proposed sale (Form 144)
Jun 8, 20264Insider transaction (Form 4)
Jun 8, 20264Insider transaction (Form 4)
Jun 8, 20264Insider transaction (Form 4)
Jun 8, 20264Insider transaction (Form 4)
Jun 8, 20264Insider transaction (Form 4)
Jun 8, 20264Insider transaction (Form 4)
Jun 8, 20264Insider transaction (Form 4)
Jun 5, 20264Insider transaction (Form 4)
Jun 5, 20264Insider transaction (Form 4)
Jun 5, 20264Insider transaction (Form 4)

The newest 25 of 62 shown; the full year is on EDGAR.

2025 · 66 filings — 49 × 4, 13 × 144, 1 × 11-K and 3 other forms
FiledWhat it is
Nov 25, 20254Insider transaction (Form 4)
Nov 21, 2025144Notice of proposed sale (Form 144)
Nov 20, 20254Insider transaction (Form 4)
Nov 18, 2025144Notice of proposed sale (Form 144)
Nov 13, 20254Insider transaction (Form 4)
Nov 12, 2025144Notice of proposed sale (Form 144)
Nov 4, 2025SCHEDULE 13G/AOther filings
Oct 8, 20254Insider transaction (Form 4)
Oct 6, 2025144Notice of proposed sale (Form 144)
Oct 3, 20254Insider transaction (Form 4)
Oct 3, 20254Insider transaction (Form 4)
Oct 3, 20254Insider transaction (Form 4)
Oct 3, 20254Insider transaction (Form 4)
Oct 3, 20254Insider transaction (Form 4)
Oct 3, 20254Insider transaction (Form 4)
Oct 3, 20254Insider transaction (Form 4)
Aug 22, 20254Insider transaction (Form 4)
Aug 20, 2025144Notice of proposed sale (Form 144)
Aug 15, 20254Insider transaction (Form 4)
Aug 12, 20254Insider transaction (Form 4)
Aug 12, 20254Insider transaction (Form 4)
Aug 12, 20254Insider transaction (Form 4)
Aug 12, 20254Insider transaction (Form 4)
Aug 12, 20254Insider transaction (Form 4)
Aug 12, 20254Insider transaction (Form 4)

The newest 25 of 66 shown; the full year is on EDGAR.

2024 · 80 filings — 54 × 4, 11 × 144, 6 × SC 13G/A and 6 other forms
FiledWhat it is
Nov 27, 20244Insider transaction (Form 4)
Nov 25, 2024144Notice of proposed sale (Form 144)
Nov 8, 2024SC 13G/APassive holder above 5% (Schedule 13G), amended
Oct 21, 2024SC 13G/APassive holder above 5% (Schedule 13G), amended
Oct 2, 20244Insider transaction (Form 4)
Oct 2, 20244Insider transaction (Form 4)
Oct 2, 20244Insider transaction (Form 4)
Oct 2, 20244Insider transaction (Form 4)
Oct 2, 20244Insider transaction (Form 4)
Oct 2, 20244Insider transaction (Form 4)
Oct 2, 20244/AInsider transaction (Form 4), amended
Sep 17, 20244Insider transaction (Form 4)
Sep 12, 20244Insider transaction (Form 4)
Sep 10, 2024144Notice of proposed sale (Form 144)
Aug 12, 20244Insider transaction (Form 4)
Aug 12, 20244Insider transaction (Form 4)
Aug 12, 20244Insider transaction (Form 4)
Aug 12, 20244Insider transaction (Form 4)
Aug 12, 20244Insider transaction (Form 4)
Aug 12, 20244Insider transaction (Form 4)
Aug 12, 20244Insider transaction (Form 4)
Aug 12, 20244Insider transaction (Form 4)
Aug 12, 20244Insider transaction (Form 4)
Jun 21, 202411-KEmployee plan annual report
Jun 7, 20244Insider transaction (Form 4)

The newest 25 of 80 shown; the full year is on EDGAR.

2023 · 57 filings — 43 × 4, 5 × 144, 3 × SC 13G/A and 4 other forms

Counted, not listed; the year is on EDGAR.

2022 · 50 filings — 45 × 4, 3 × SC 13G/A, 1 × 11-K and 1 other form

Counted, not listed; the year is on EDGAR.

2021 · 84 filings — 51 × 4, 11 × 425, 3 × SC 13G/A and 17 other forms

Counted, not listed; the year is on EDGAR.

2020 · 56 filings — 45 × 4, 3 × 3, 2 × 4/A and 5 other forms

Counted, not listed; the year is on EDGAR.

2019 · 108 filings — 74 × 4, 21 × 3, 4 × 4/A and 8 other forms

Counted, not listed; the year is on EDGAR.

2018 · 2 filings — 1 × 425, 1 × S-4

Counted, not listed; the year is on EDGAR.

About this data#

STERIS plc (Ireland) (STE) has 680 filings on EDGAR going back to 2018: 8 annual reports, 22 quarterly reports and 64 current reports, plus proxy statements, insider forms and ownership schedules. Its latest annual report, a 10-K, was filed on May 29, 2026 for the fiscal year ended Mar 31, 2026. The most recent 8-K, on Oct 13, 2026, covered material definitive agreement. Over the last 13 months insiders sold $3.2M in 6 sales and bought nothing on the open market; 75 other transactions (awards, exercises, tax withholding, gifts and plan purchases). Not investment advice.

Every row is a filing EDGAR lists for the registrants that have been STERIS plc (Ireland), read from the SEC’s submissions index each morning; a filing accepted after that read appears the next day. Where a company changed its filing entity (a holding-company reorganisation, Google into Alphabet) the predecessor’s filings are shown for the years it filed as the company, derived from the filings themselves. Dates are the filing date; the period is the report’s own. The latest 3 years of reports are listed in full, the next years to 10 without their 8-Ks, and older years are counted; the other forms are counted too, with the newest 25 of each of the latest 3 years shown. Insider transactions are the Form 4 and Form 5 documents themselves, filed since January 2026, every number as the insider filed it: a day’s lots are summed, a blank price adds its shares and no dollars, and a purchase through an employee stock plan is a plan purchase, not insider buying. An 8-K’s headline is the first line of the press release it furnishes (Exhibit 99), read from the filing and shown word for word; where two independent readings of the exhibit do not agree, the 8-K is described by its items instead. The documents stay on sec.gov, public domain, and every link opens the SEC’s copy. ChartRow does not summarise or interpret filings.

FAQ#

Where can I read STE's latest 10-K?
STE's latest annual report, a 10-K, was filed on May 29, 2026 for the fiscal year ended Mar 31, 2026. It is linked above and opens on EDGAR, the SEC's own site, where every exhibit is also listed.
When did STE last file an 8-K?
On Oct 13, 2026 it covered material definitive agreement. An 8-K reports a material event between quarterly reports; the one that furnishes the quarter's results is filed under Item 2.02, last on Aug 5, 2026.
Are STE insiders buying or selling?
Over the last 13 months insiders sold $3.2M in 6 sales and bought nothing on the open market; 75 other transactions (awards, exercises, tax withholding, gifts and plan purchases). The most recent sale: Sohi Mohsen (Director) sold 4,058 shares on Aug 12, 2026 for $957K. Every figure is as the insider filed it on Form 4; a sale under a 10b5-1 plan was scheduled in advance.
How many SEC filings has STE made?
680 filings are on EDGAR under the registrant records that have been STERIS plc (Ireland), going back to 2018; 484 of them are insider ownership forms (Forms 3, 4, 5 and 144).